Skip to main content
. 2018 Dec 4;2018(12):CD011902. doi: 10.1002/14651858.CD011902.pub2
Study author
 
 Other target conditions reported Study type
 Country
 Setting Inclusion criteria Index tests (algorithm)
Diagnostic approach
Threshold Observer qualifications (number)
Experience
Reference standard
Final diagnoses
Prevalence (any skin cancer)
Exclusions
Comments (marked *)
In‐person evaluations          
Argenziano 2006 RCT
Italy, Spain
Primary
NR/85
Patients asking for screening or exhibiting ≥ 1 skin tumours as seen during routine physical examination (patient‐finding screening).
Participating PCPs randomised to either visual inspection alone or visual inspection + dermoscopy; only excised lesions can be included for each arm.
VI (ABCD)
Dermoscopy (3‐point checklist)
In‐person (single observer)
Subjective impression; diagnosis of malignancy GPs (n = 37)
All trained in ABCD rule
Histology
MEL 6
BCC 37; SCC 10
Benign 32
53/85; 62%
*Only those patients who were considered to have lesions suggestive of skin cancer had histology and could be included; rest had expert diagnosis (making full dataset ineligible for this review)
Durdu 2011
Invasive melanoma or atypical intraepidermal melanocytic variants
WPC
P‐CS
Secondary
Turkey
176/200
PSL that could not be diagnosed with only dermatologic physical examination; 2x2 included for melanocytic subset Dermoscopy (ABCD; nonmelanocytic excluded first)
(Also evaluated exfoliative cytology)
In‐person
NR Dermatologist (n = 1; exp NR)
Single observer
Histology
MEL: 10; BCC: 34; other malignant 2
SK 24; BN 100; DF 12; warts 16; dirt 1; other 1
10/200; 5%
Soyer 2004 NC
R‐CS
Specialist unit
Italy
225/231
Lesions at pigmented lesion clinic considered by experienced dermatologists to merit excision on clinical grounds Dermoscopy (no algorithm)
In‐person
NR Dermatologist (n = 1; exp High)*
Single
Histology
MEL: 68; BCC 9
'Benign' 154
77/154; 33%
*Also reports data for 6 inexperienced observers interpretation of the acquired dermoscopic images; data excluded as includes 3 medical students
Stanganelli 2000
Invasive melanoma or atypical intraepidermal melanocytic variants
WPC
R‐CS
Italy
Specialist clinic
NR/3372
PSL referred by dermatologists and general practitioners either for pre‐surgical assessment or consultation VI (ABCD)
 Dermoscopy (no algorithm)
In person (single)
NR
 Subjective impression NR (assumed dermatologist ‐ described as one of the co‐authors; n = 1) Histology/registry FU
MEL 55
BCC 43; benign 3274
98/3372; 3%
NR
Image‐based evaluations
Carli 2002b
Invasive melanoma or atypical intraepidermal melanocytic variants
Any
WPC
R‐CS
Italy
Secondary
NR/57
Clinically suspicious or equivocal PSL undergoing excision for diagnostic purposes; all ≤ 14 mm diameter 1. VI (NR)
 2. Dermoscopy (NR)
Image‐based (blinded)
NR Dermatologists (n = 2)
High exp ('with experience in the field of '); consensus of 2
Histology
MM 6, MiS 5
BCC 10
BN 31, SK 1; other 4
11/57; 19%
4 ‘not evaluables’ excluded (NB these differ between clinical images and dermoscopic images (1 MM excluded from VI analysis)
Lorentzen 2008
Invasive melanoma
WPC
NR‐CS Specialist clinic
Denmark
119/119
Patients referred to the specialist naevus clinic; compared classic dermoscopy to acrylic globe magnifier Dermoscopy (Kenet risk stratification)
Image‐based (blinded)
NR Dermatologist (n = NR)
Average
Histology
MM 24; BCC 13
BN 69; mild/moderate dysplasia 2; SK 9; other 2
24/119; 20%
1 DF
Rosendahl 2011
Invasive melanoma or atypical intraepidermal melanocytic variants
WPC‐algorithms
R‐CS
Australia
Primary
389/463
PSL submitted for histology from the primary care skin cancer practice of 1 author 1. VI (no algorithm)
2. Dermoscopy (pattern; Chaos and Clues)
1. Subjective impression
2. NR; both characteristics present
Dermatologist (n = 1)
High exp (confirmed by author); single obs
Histology
MM 9; MiS 20
BCC 72; SCC 5
BN 217; BD 18; AK 14*; BNM 140
*considered malignant by study authors
29/463; 6%
3 poor‐quality images excluded
Stanganelli 1998a
Invasive melanoma or atypical intraepidermal melanocytic variants
Any
WPC
R‐CS
Italy
Training images
Italy
NR/30
PSL images selected from computerised files of the skin cancer clinic 1. VI (no algorithm)
 2. Dermoscopy (no algorithm)
Image‐based (clinical image)
NR; clinical diagnosis Dermatologists (n = 20)
Exp NR (“experience in ELM but (with) no formal training”)
Average result
Histology
MEL 10
BCC 4
BN 10, SK 3, other 3
10/30; 33%
NR
BCC results not disaggregated
Zalaudek 2006
Invasive melanoma or atypical intraepidermal melanocytic variants
NC
R‐CS
Specialist clinic
Italy
NR/165
Random sample of excised, equivocal and nonequivocal, PSL and non‐PSLs with melanin or haemoglobin pigmentation in all or part of the lesion Dermoscopy (3PCL)
Image‐based (age, site, gender)
≥ 2 characteristics present Mixed (n = 150; exp NR)
Average result
Histology
Full sample:
MM 18; MiS 11
BCC: 18
79 BN; 26 SK; 8 vascular; 3 DF
26/150; 17%
15 used for training purposes
5 BCC moved from FP to TN
3PCL: three‐point checklist; AK: actinic keratosis; alg: algorithm; BD: Bowen’s disease; BCC: basal cell carcinoma; BN: benign naevi; BPC: between person comparison (of tests);CAD: computer‐assisted diagnosis; CCS: case‐control study; CS: case series; cSCC: cutaneous squamous cell carcinoma; DF: dermatofibroma; ELM: epiluminescence microscopy; exp: experience; FP: false positive; FU: follow‐up; LS: lentigo simplex; MiS: melanoma in situ (or lentigo maligna); MM: malignant melanoma; NC: non‐comparative; NR: not reported; Obs: observer; P: prospective; PCP: primary care provider; PLC: pigmented lesion clinic; PSL: pigmented skin lesion; R: retrospective; RCM: reflectance confocal microscopy; SK: seborrhoeic keratosis; SN: Spitz naevi; TN: true negative; VI: visual inspection; WPC: within person comparison (of tests)